Expression and release of angiopoietin-1 from human neutrophils: Intracellular mechanisms

Growth Factors

Volumn 27, Issue 6, 2009, Pages 335-344

  Neagoe, Paul Eduard ^a   Brkovic, Alexandre ^a   Hajjar, Fadi ^a   Sirois, Martin G ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Cell activation; Cytokines; Human; Inflammation; Neutrophils

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; FORMYLMETHIONYLLEUCYLPHENYLALANINE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATE BUFFERED SALINE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOSOLIC FRACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; NEUTROPHIL; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANGIOPOIETIN-1; CELLS, CULTURED; HUMANS; INFLAMMATION; NEOVASCULARIZATION, PATHOLOGIC; NEUTROPHIL ACTIVATION; NEUTROPHILS; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 70450183812     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977190903155043     Document Type: Article

References (63)

1. Ancelin M, Chollet-Martin S, Herve MA, Legrand C, El Benna J, Perrot-Applanat M. 2004. Vascular endothelial growth factor VEGF189 induces human neutrophil chemotaxis in extravascular tissue via an autocrine amplification mechanism. Lab Invest 84(4):502-512.
2. Baranes D, Matzner J, Razin E. 1986. Thrombin-induced calciumindependent degranulation of human neutrophils. Inflammation 10(4):455-461.
3. Boxer LA, Axtell R, Suchard S. 1990. The role of the neutrophil in inflammatory diseases of the lung. Blood Cells 16(1):25-40; discussion 41-42.
4. Brkovic A, Pelletier M, Girard D, Sirois MG. 2007. Angiopoietin chemotactic activities on neutrophils are regulated by PI-3K activation. J Leukoc Biol 81(4):1093-1101.
5. Carmeliet P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6(4):389-395.
6. Carmeliet P. 2003. Angiogenesis in health and disease. Nat Med 9(6):653-660.
7. Carmeliet P, Jain RK. 2000. Angiogenesis in cancer and other diseases. Nature 407(6801):249-257.
8. Chibber R, Castle AG. 1983. Subcellular fractionation of porcine neutrophils by nitrogen cavitation and sucrose-density-gradient centrifugation. Eur J Biochem 136(2):383-389.
9. Currie MS, Rao KM, Padmanabhan J, Jones A, Crawford J, Cohen HJ. 1990. Stimulus-specific effects of pentoxifylline on neutrophil CR3 expression, degranulation, and superoxide production. J Leukoc Biol 47(3):244-250.
10. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD. 1996. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87(7):1161-1169. (Pubitemid 27010100)
11. de Muinck ED, Simons M. 2004. Re-evaluating therapeutic neovascularization. J Mol Cell Cardiol 36(1):25-32.
12. DeBusk LM, Chen Y, Nishishita T, Chen J, Thomas JW, Lin PC. 2003. Tie2 receptor tyrosine kinase, a major mediator of tumor necrosis factor alpha-induced angiogenesis in rheumatoid arthritis. Arthritis Rheum 48(9):2461-2471.
13. Dor Y, Djonov V, Abramovitch R, Itin A, Fishman GI, Carmeliet P, Goelman G, Keshet E. 2002. Conditional switching of VEGF provides new insights into adult neovascularization and proangiogenic therapy. EMBO J 21(8):1939-1947.
14. Faurschou M, Borregaard N. 2003. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 5(14):1317-1327.
15. Feistritzer C, Mosheimer BA, Sturn DH, Bijuklic K, Patsch JR, Wiedermann CJ. 2004. Expression and function of the angiopoietin receptor Tie-2 in human eosinophils. J Allergy Clin Immunol 114(5):1077-1084.
16. Folkman J. 2002. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29(6 Suppl 16):15-18.
17. Gaudry M, Bregerie O, Andrieu V, El Benna J, Pocidalo MA, Hakim J. 1997. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 90(10):4153-4161.
18. Hashiramoto A, Sakai C, Yoshida K, Tsumiyama K, Miura Y, Shiozawa K, Nose M, Komai K, Shiozawa S. 2007. Angiopoietin 1 directly induces destruction of the rheumatoid joint by cooperative, but independent, signaling via ERK/MAPK and phosphatidylinositol 3-kinase/Akt. Arthritis Rheum 56(7):2170-2179.
19. Hayes AJ, Huang WQ, Yu J, Maisonpierre PC, Liu A, Kern FG, Lippman ME, McLeskey SW, Li LY. 2000. Expression and function of angiopoietin-1 in breast cancer. Br J Cancer 83(9):1154-1160.
20. Hegen A, Koidl S, Weindel K, Marme D, Augustin HG, Fiedler U. 2004. Expression of angiopoietin-2 in endothelial cells is controlled by positive and negative regulatory promoter elements. Arterioscler Thromb Vasc Biol 24(10):1803-1809.
21. Hu B, Jarzynka MJ, Guo P, Imanishi Y, Schlaepfer DD, Cheng SY. 2006. Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway. Cancer Res 66(2):775-783.
22. Jones N, Iljin K, Dumont DJ, Alitalo K. 2001. Tie receptors: New modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol 2(4):257-267.
23. Kerbel R, Folkman J. 2002. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2(10):727-739.
24. Kitsis E, Weissmann G. 1991. The role of the neutrophil in rheumatoid arthritis. Clin Orthop Relat Res(265):63-72.
25. Kjeldsen L, Sengelov H, Borregaard N. 1999. Subcellular fractionation of human neutrophils on Percoll density gradients. J Immunol Methods 232(1-2):131-143. (Pubitemid 30017771)
26. Klebanoff SJ, Vadas MA, Harlan JM, Sparks LH, Gamble JR, Agosti JM, Waltersdorph AM. 1986. Stimulation of neutrophils by tumor necrosis factor. J Immunol 136(11):4220-4225.
27. Kukk E,Wartiovaara U, Gunji Y, Kaukonen J, Buhring HJ, Rappold I, Matikainen MT, Vihko P, Partanen J, Palotie A, Alitalo K, Alitalo R. 1997. Analysis of Tie receptor tyrosine kinase in haemopoietic progenitor and leukaemia cells. Br J Haematol 98(1):195-203.
28. Lee OH, Xu J, Fueyo J, Fuller GN, Aldape KD, Alonso MM, Piao Y, Liu TJ, Lang FF, Bekele BN, Gomez-Manzano C. 2006. Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin beta1-dependent adhesion to the extracellular matrix. Mol Cancer Res 4(12):915-926.
29. Lemieux C, Maliba R, Favier J, Theoret JF, Merhi Y, Sirois MG. 2005. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood 105(4):1523-1530.
30. Li JJ, Huang YQ, Basch R, Karpatkin S. 2001. Thrombin induces the release of angiopoietin-1 from platelets. Thromb Haemost 85(2):204-206.
31. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277(5322):55-60.
32. Makinde T, Agrawal DK. 2008. Intra and extra-vascular transmembrane signaling of angiopoietin-1-Tie2 receptor in health and disease. J Cell Mol Med.
33. Maliba R, Lapointe S, Neagoe PE, Brkovic A, Sirois MG. 2006. Angiopoietins-1 and -2 are both capable of mediating endothelial PAF synthesis: Intracellular signalling pathways. Cell Signal 18(11):1947-1957.
34. Maliba R, Brkovic A, Neagoe PE, Villeneuve LR, Sirois MG. 2008. Angiopoietin-mediated endothelial P-selectin translocation: Cell signaling mechanisms. J Leukoc Biol 83(2):352-360.
35. Mochizuki Y, Nakamura T, Kanetake H, Kanda S. 2002. Angiopoietin 2 stimulates migration and tube-like structure formation of murine brain capillary endothelial cells through c-Fes and c-Fyn. J Cell Sci 115(Pt 1):175-183.
36. Murdoch C, Tazzyman S, Webster S, Lewis CE. 2007. Expression of Tie-2 by human monocytes and their responses to angiopoietin-2. J Immunol 178(11):7405-7411.
37. Nakayama T, Hatachi G, Wen CY, Yoshizaki A, Yamazumi K, Niino D, Sekine I. 2005. Expression and significance of Tie-1 and Tie-2 receptors, and angiopoietins-1, 2 and 4 in colorectal adenocarcinoma: Immunohistochemical analysis and correlation with clinicopathological factors. World J Gastroenterol 11(7):964-969.
38. Nishishita T, Lin PC. 2004. Angiopoietin 1, PDGF-B, and TGFbeta gene regulation in endothelial cell and smooth muscle cell interaction. J Cell Biochem 91(3):584-593.
39. O'Flaherty JT. 1985. Neutrophil degranulation: Evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE. J Cell Physiol 122(2):229-239.
40. Renko M, Quarto N, Morimoto T, Rifkin DB. 1990. Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J Cell Physiol 144(1):108-114.
41. Richter J, Andersson T, Olsson I. 1989. Effect of tumor necrosis factor and granulocyte/macrophage colony-stimulating factor on neutrophil degranulation. J Immunol 142(9):3199-3205.
42. Sallenave JM, Si Tahar M, Cox G, Chignard M, Gauldie J. 1997. Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils. J Leukoc Biol 61(6):695-702.
43. Seligmann BE, Fletcher MP, Gallin JI. 1983. Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes. J Immunol 130(4):1902-1909.
44. Sengelov H, Kjeldsen L, Borregaard N. 1993. Control of exocytosis in early neutrophil activation. J Immunol 150(4):1535-1543.
45. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. 1983. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219(4587):983-985.
46. Shahrara S, Volin MV, Connors MA, Haines GK, Koch AE. 2002. Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue. Arthritis Res 4(3):201-208.
47. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376(6535):62-66.
48. Shaw JP, Basch R, Shamamian P. 2004. Hematopoietic stem cells and endothelial cell precursors express Tie-2, CD31 and CD45. Blood Cells Mol Dis 32(1):168-175.
49. Shen L, Smith JM, Shen Z, Eriksson M, Sentman C, Wira CR. 2007. Inhibition of human neutrophil degranulation by transforming growth factor-beta1. Clin Exp Immunol 149(1):155-161.
50. Shyu KG, Chang H, Isner JM. 2003. Synergistic effect of angiopoietin-1 and vascular endothelial growth factor on neoangiogenesis in hypercholesterolemic rabbit model with acute hindlimb ischemia. Life Sci 73(5):563-579.
51. Stratmann A, Risau W, Plate KH. 1998. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 153(5):1459-1466.
52. Sturn DH, Feistritzer C, Mosheimer BA, Djanani A, Bijuklic K, Patsch JR, Wiedermann CJ. 2005. Angiopoietin affects neutrophil migration. Microcirculation 12(5):393-403.
53. Sundberg C, Kowanetz M, Brown LF, Detmar M, Dvorak HF. 2002. Stable expression of angiopoietin-1 and other markers by cultured pericytes: Phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo. Lab Invest 82(4):387-401.
54. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, Yancopoulos GD. 1998. Increased vascularization in mice overexpressing angiopoietin-1. Science 282(5388):468-471.
55. Tait CR, Jones PF. 2004. Angiopoietins in tumours: The angiogenic switch. J Pathol 204(1):1-10.
56. Takahara K, Iioka T, Furukawa K, Uchida T, Nakashima M, Tsukazaki T, Shindo H. 2004. Autocrine/paracrine role of the angiopoietin-1 and -2/Tie2 system in cell proliferation and chemotaxis of cultured fibroblastic synoviocytes in rheumatoid arthritis. Hum Pathol 35(2):150-158.
57. Teichert-Kuliszewska K, Maisonpierre PC, Jones N, Campbell AI, Master Z, Bendeck MP, Alitalo K, Dumont DJ, Yancopoulos GD, Stewart DJ. 2001. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc Res 49(3):659-670.
58. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM. 1999. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286(5449):2511-2514.
59. Uchida T, Nakashima M, Hirota Y, Miyazaki Y, Tsukazaki T, Shindo H. 2000. Immunohistochemical localisation of protein tyrosine kinase receptors Tie-1 and Tie-2 in synovial tissue of rheumatoid arthritis: Correlation with angiogenesis and synovial proliferation. Ann Rheum Dis 59(8):607-614.
60. Wright DG, Bralove DA, Gallin JI. 1977. The differential mobilization of human neutrophil granules. Effects of phorbol myristate acetate and ionophore A23187. Am J Pathol 87(2):237-284.
61. YancopoulosGD, Davis S, GaleNW, Rudge JS, Wiegand SJ, Holash J. 2000. Vascular-specific growth factors and blood vessel formation. Nature 407(6801):242-248.
62. Yasuda M, Tanaka Y, Tamura M, Fujii K, Sugaya M, So T, Takenoyama M, Yasumoto K. 2001. Stimulation of beta1 integrin down-regulates ICAM-1 expression and ICAM-1- dependent adhesion of lung cancer cells through focal adhesion kinase. Cancer Res 61(5):2022-2030.
63. Zimmerman BJ, Granger DN. 1994. Mechanisms of reperfusion injury. Am J Med Sci 307(4):284-292.